Acclaimed actor Sam Neill, famous for his Jurassic Park role, has passed away. His family confirmed his death on Monday, July ...

Chimeric antigen receptor (CAR) T-cell therapy represents a paradigm shift in the treatment of relapsed or refractory haematological cancers by harnessing patients’ own immune cells to target surface ...

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, ...

Clinical outcomes from a prospective study of comprehensive genomic testing in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the ...

Effect of Prehabilitation Interventions in People Affected by Bladder Cancer on Long-Term Physical, Clinical, and Patient-Reported Outcome Measures: A Systematic Review Chimeric antigen receptor ...

CAR T-cell therapy, a revolutionary cancer treatment known as the living drug, has shown remarkable success in combating ...

An exciting, new, one-off cancer therapy that has shown an almost 100 per cent cure rate treating solid tumours in mice will be tested in humans thanks to a major research grant to be announced on ...

The trial is enrolling adult women with recurrent ovarian cancer after at least two previous therapies. Credit: Jo Panuwat D / Shutterstock.com. (Jo Panuwat D / Shutterstock.com.) Anixa Biosciences ...

A new paper from MUSC Hollings Cancer Center researchers is helping to reveal the "rules" for engineering chimeric antigen receptor (CAR) Tregs. Tregs, or T-regulatory cells, have shown promise in ...

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

LOS ANGELES--(BUSINESS WIRE)--Physician-researchers with City of Hope ®, one of the largest cancer research and treatment organizations in the United States with its National Medical Center named Top ...